Addressing Inflammation in Chronic Diseases: A Functional Medicine Perspective
Temperature excursions, freeze-thaw cycles, and contamination are all preventable with the right equipment and technique
That mechanism is the entire point, and it works: roughly 18% of US adults have tried a GLP-1 and about 12% are currently taking one (KFF Health Tracking Poll), according to KFF survey data
88,89 In addition, conclusions regarding uncommon or delayed adverse events are derived largely from observational studies and pharmacovigilance datasets, highlighting the need for adequately powered, long-term real-world safety investigations
This approach ensures safety, efficacy, and appropriate dosing